Perspective Therapeutics CATX Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Perspective Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Perspective Therapeutics's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Perspective Therapeutics's accounts receivable?
- Perspective Therapeutics (CATX) reported accounts receivable of $58K in Q1 2026.
- How has Perspective Therapeutics's accounts receivable changed year-over-year?
- Perspective Therapeutics's accounts receivable decreased by 25.6% year-over-year, from $78K to $58K.
- What is the long-term trend for Perspective Therapeutics's accounts receivable?
- Over 5 years (2020 to 2025), Perspective Therapeutics's accounts receivable has grown at a -67.8% compound annual growth rate (CAGR), from $1.74M to $6K.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.